Tobias M Dantonello

Summary

Country: Germany

Publications

  1. ncbi Malignant ectomesenchymoma in children and adolescents: report from the Cooperative Weichteilsarkom Studiengruppe (CWS)
    Tobias M Dantonello
    Olgahospital, Pediatrics 5 Oncology, Hematology, Immunology, Rheumatology, Gastroenterology and General Pediatrics, Klinikum Stuttgart, Germany
    Pediatr Blood Cancer 60:224-9. 2013
  2. ncbi Initial patient characteristics can predict pattern and risk of relapse in localized rhabdomyosarcoma
    Tobias M Dantonello
    Olgahospital, Pediatrics 5 Oncology, Hematology, Immunology, Klinikum Stuttgart, Bismarckstrasse 8, D 70176 Stuttgart, Germany
    J Clin Oncol 26:406-13. 2008
  3. ncbi Mesenchymal chondrosarcoma of soft tissues and bone in children, adolescents, and young adults: experiences of the CWS and COSS study groups
    Tobias M Dantonello
    Pediatrics 5 Oncology, Hematology, Immunology, Olgahospital, Klinikum Stuttgart, Stuttgart, Germany
    Cancer 112:2424-31. 2008
  4. ncbi Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adults
    Tobias M Dantonello
    Olgahospital, Pediatrics 5 Oncology, Hematology, and Immunology, and Katharinenhospital, Department of Radiotherapy, Klinikum Stuttgart, Germany
    J Clin Oncol 27:1446-55. 2009
  5. ncbi Embryonal rhabdomyosarcoma with metastases confined to the lungs: report from the CWS Study Group
    Tobias M Dantonello
    Pediatrics 5 Oncology, Hematology, Immunology, Olgahospital, Klinikum Stuttgart, Germany
    Pediatr Blood Cancer 56:725-32. 2011

Detail Information

Publications5

  1. ncbi Malignant ectomesenchymoma in children and adolescents: report from the Cooperative Weichteilsarkom Studiengruppe (CWS)
    Tobias M Dantonello
    Olgahospital, Pediatrics 5 Oncology, Hematology, Immunology, Rheumatology, Gastroenterology and General Pediatrics, Klinikum Stuttgart, Germany
    Pediatr Blood Cancer 60:224-9. 2013
    ..To date merely 50 cases have been published and the knowledge about the course of disease and optimal treatment is limited...
  2. ncbi Initial patient characteristics can predict pattern and risk of relapse in localized rhabdomyosarcoma
    Tobias M Dantonello
    Olgahospital, Pediatrics 5 Oncology, Hematology, Immunology, Klinikum Stuttgart, Bismarckstrasse 8, D 70176 Stuttgart, Germany
    J Clin Oncol 26:406-13. 2008
    ....
  3. ncbi Mesenchymal chondrosarcoma of soft tissues and bone in children, adolescents, and young adults: experiences of the CWS and COSS study groups
    Tobias M Dantonello
    Pediatrics 5 Oncology, Hematology, Immunology, Olgahospital, Klinikum Stuttgart, Stuttgart, Germany
    Cancer 112:2424-31. 2008
    ..As reports about MCS in young patients are scarce, treatment and outcomes of children/adolescents/young adults in the CWS and COSS studies were investigated...
  4. ncbi Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adults
    Tobias M Dantonello
    Olgahospital, Pediatrics 5 Oncology, Hematology, and Immunology, and Katharinenhospital, Department of Radiotherapy, Klinikum Stuttgart, Germany
    J Clin Oncol 27:1446-55. 2009
    ..To improve risk-adapted therapy for localized childhood soft tissue sarcoma within an international multicenter setting...
  5. ncbi Embryonal rhabdomyosarcoma with metastases confined to the lungs: report from the CWS Study Group
    Tobias M Dantonello
    Pediatrics 5 Oncology, Hematology, Immunology, Olgahospital, Klinikum Stuttgart, Germany
    Pediatr Blood Cancer 56:725-32. 2011
    ..Embryonal rhabdomyosarcoma [RME] is the most common pediatric soft tissue sarcoma. Whereas the prognosis of localized rhabdomyosarcoma has improved, it remains poor for metastatic disease...